THE VOGEL GROUP

Lobbying for NEPHRON PHARMACEUTICALS CORPORATION · Developer and manufacturer of sterile inhalation and 503B outsourcing medication.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · South Carolina · $50,000.00 income · posted Apr 20, 2026

Lobbying activity 1

Pharmacy

Issues relating to facility operations

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem